肠道微生物群在克罗恩氏病的发病过程中
Dogukan Ozbey1,2, Suat Saribas1, Bekir Kocazeybek3
1Department of Medical Microbiology, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul 34098, Türkiye.
World journal of gastroenterology
|February 17, 2025
概括
便微生物种移植 (FMT) 显示出炎症性肠道疾病 (IBD) 的潜力,特别是克罗恩病 (CD). 然而,目前的证据不足以证实长期益处或将其确定为最终治疗方法.
科学领域:
- 胃肠道学和免疫学
- 微生物组研究 微生物组研究
背景情况:
- 炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎,涉及复杂的炎症.
- 在CD中,介质脂肪膨胀 ("爬行脂肪") 受肠道细菌的影响,可能会促进纤维化.
- 肠道微生物群的组成在结肠和胆管CD之间有所不同.
研究的目的:
- 评估便微生物群移植 (FMT) 在治疗炎症性肠病 (IBD) 的有效性和局限性.
- 为了解决围绕FMT作为克罗恩病 (CD) 确定的治疗方法的不确定性.
主要方法:
- 便微生物种移植 (FMT) 涉及将肠道细菌从健康的捐赠者转移给IBD患者.
- 审查现有关于FMT在克罗恩病 (CD) 和其他IBD中的应用研究.
- 分析影响FMT有效性的因素,包括捐赠者的变异性和疾病的位置.
主要成果:
- FMT的目的是恢复肠道微生物群平衡,减少炎症,并促进IBD患者的粘膜愈合.
- 一些研究表明,在CD中使用FMT可以改善症状,但长期疗效尚不清楚.
- 仍然存在关于FMT效益的持续时间和CD重复治疗的必要性的问题.
结论:
- 便微生物种移植 (FMT) 对炎症性肠道疾病 (IBD) 是有前途的,但对于克罗恩病 (CD) 需要进一步研究.
- 对于在IBD管理中提供持续的长期益处的治疗策略有着至关重要的需求.
- 目前的证据并不完全支持FMT作为对CD的最终治疗方法,原因是疗效和耐久性的不确定性.
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
166
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
166
01:17Irritable Bowel Syndrome I: Introduction
226
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
226
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
122
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
122
01:17Chronic Bowel Disorders: Introduction
380
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
380
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
301
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
301
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
110
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
110